Refine by MP, party, committee, province, or result type.

Results 1-15 of 15
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  I have nothing to add over what Gillian said, except to say that the science and the initiatives are there. We need to use them.

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  We did a study on it. On average, it adds about eight minutes, and it's minimal blood loss. With regard to the developing country point, my resident just came back from Kenya, where they're doing opportunistic salpingectomies.

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  I would say it's knowledge translation. If you're not talking about it and your patient is not asking about it and your residents aren't bugging you to do it, it's easier to just not do it. I think that speaks to some themes you've heard today—that if there's good science, you st

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  I would add very quickly that for each initiative, we have tool kits and education, things that we're trying to build for family practitioners and general gynecologists, not just the cancer specialists in the room. Those are things that probably could use better funding and suppo

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  Not that I'm aware of. Dr. Hanley, do you...?

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  I can comment a bit, as we've rolled this out in British Columbia with self-screening. We also have a crisis, which has been mentioned by many of the members already, of a shortage of family physicians. There are clauses in there for how to deal with a result if you don't have

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  May I—

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  Is that in terms of prevention or in terms of treatment?

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  I guess in some things, I would say, for opportunistic salpingectomy, we're actually the global leaders. The statistics and uptakes on that are fantastic. Prevention or screening is difficult anywhere in ovarian cancer. I would say that we all globally struggle. There are diffe

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  You're right. We don't have screening like we do for cervical cancer. We don't even have a heralding symptom like endometrial cancer, where you might spot or bleed. Usually when you have symptoms with ovarian cancer, it's already at an advanced stage. There are very good intern

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  We're really excited and proud in British Columbia with the self-screening. As you can imagine, it helps to reduce the barriers of tremendous geographic distance, history of trauma, those who have traditionally not been within the screening system, and the disproportionate number

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  That's a wise question, and you've hit the nail on the head. I think it would go tremendously far. What you've heard about today from all of us—and again, it's lovely to be on this panel with so many people we respect and who are all working toward the same goals—is that yes, th

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  Cervical cancer, first of all, has probably a two-year lag period between pre-cancer and advanced cancer, with all those opportunities to either prevent it with vaccinations and screening, as Shannon Salvador mentioned, or to intervene and cure it. There are great opportunities t

February 12th, 2024Committee meeting

Dr. Jessica McAlpine

Health committee  Thank you very much. Thanks for the opportunity to be part of today's session. I'm a surgeon, scientist and professor at UBC. I spend half of my time in surgery and seeing patients with gynecological cancers and half in translational research. You have heard from my colleagues

February 12th, 2024Committee meeting

Dr. Jessica McAlpine